2-Deoxy-D-glucose
Alternative Names: 2-Deoxyglucose; 2-DGLatest Information Update: 21 Feb 2023
At a glance
- Originator Threshold Pharmaceuticals
- Developer Threshold Pharmaceuticals; University of Virginia; University of Wisconsin-Madison
- Class Antiepileptic drugs; Antivirals; Deoxy sugars; Small molecules
- Mechanism of Action Antimetabolites; Glucose modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase II Epilepsy
- No development reported Brain injuries
- Discontinued Solid tumours
Most Recent Events
- 02 Sep 2022 Phase-II clinical trials in Epilepsy (In adults, In the elderly) in USA (PO) (NCT05605301)
- 28 Jul 2018 No recent reports of development identified for preclinical development in Brain injuries in USA
- 28 Jul 2018 No recent reports of development identified for preclinical development in Epilepsy in USA (PO)